The ACRG had classified 300 GAc cases into MSI tumours (22.7%), MSS/EMT tumours (15.3%), MSS/TP53+ (26.3%) and MSS/TP53- tumours (35.7%) [3]. The gene discussed is TP53; the disease is neoplasm.